Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Mar;7(2):141-4.
doi: 10.1128/CDLI.7.2.141-144.2000.

Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond

T F Gajewski  1
Affiliations

Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond

T F Gajewski. Clin Diagn Lab Immunol. 2000 Mar.
No abstract available

PubMed Disclaimer

References

    1. Altman J D, Moss P A H, Goulder P J R, Barouch D H, McHeyzer-Williams M G, Bell J I, McMichael A J, Davis M M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94–96. - PubMed
    1. Anichini A, Molla A, Mortarini R, Tragni G, Bersani I, Di N M, Gianni A M, Pilotti S, Dunbar R, Cerundolo V, Parmiani G. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J Exp Med. 1999;190:651–668. - PMC - PubMed
    1. Asai T, Storkus W J, Whiteside T L. Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines. Clin Diagn Lab Immunol. 2000;7:145–154. - PMC - PubMed
    1. Boon T, Cerottini J-C, Van den Eynde B, Van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337–365. - PubMed
    1. Chen Q, Jackson H, Gibbs P, Davis I D, Trapani J, Cebon J. Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects. Cancer Immunol Immunother. 1998;47:191–197. - PMC - PubMed

MeSH terms